NW Low-Glu®
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NW Low-Glu®, covering 2023-11-22 to 2023-11-22. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus [Phase 3]